Track the 에스티팜 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 에스티팜 has recorded 29 insider filings. The latest transaction was reported on 3 March 2026 (Other). Among the most active insiders: 동아쏘시오홀딩스. The full history is openly available.
28
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
20 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Estipharm is a company specialized in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and manufacturing of innovative pharmaceutical products.